The recipients of the IASLC 2023 Latin America Conference on Lung Cancer (LALCA) Education Awards were recognized during the Closing Ceremony of the conference on Friday, January 27, at the Radisson Hotel Montevideo Victoria Plaza in Montevideo, Uruguay.
The awards are presented to early career professionals, trainees, and residents who submit abstracts that are accepted for presentation at the conference. Recipients receive complimentary conference registration, up to three nights’ accommodation, a fixed amount to cover travel expenses, and free membership to the IASLC for one year.
Following are the IASLC 2023 LALCA Education Award recipients and their abstract titles:
Diego De Miguel Perez
Icahn School Of Medicine At Mount Sinai New York, United States
High Extracellular Vesicle TGF-β & PD-L1 Predict Poor Outcomes in Patients With Non-small Cell Lung Cancer Undergoing Immune-Checkpoint Inhibitors
Ana Laura Seneda
Faculty Of Medicine, São Paulo State University (UNESP), Brazil
Novel MicroRNAs Identified in Lung Cancer and Associated With Malignant Metabolism (In Silico)
Aléxia Siqueira
Molecular Oncology Research Center, Barretos Cancer Hospital, Brazil
12-Gene Expression Signature: A Potential Key for Predicting Prognosis and Benefit to ACT for Resectable NSCLC Patients
Samuel Kareff
University Of Miami Sylvester Comprehensive Cancer Center/ Jackson Memorial Hospital, United States
Rate of Pathogenic Germline Variants Detected in ctDNA Among Patients With Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population
Rodrigo de Oliveira Cavagna
Barretos Cancer Hospital, Brazil
Disruptive and Truncating TP53 Mutations Are Frequent in Lung Adenocarcinoma Patients With African Ancestry and Show Worse Prognosis
